Regeneus Ltd
ASX:RGS
Regeneus Ltd
ASX:RGS
Price:
0.009 AUD
Market Closed
Updated:
May 26, 2024
Regeneus Ltd
Selling, General & Administrative
|
Regeneus Ltd
Selling, General & Administrative Peer Comparison
Comparables:
MSB
CSL
CUV
TLX
PYC
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Regeneus Ltd
ASX:RGS
|
Selling, General & Administrative
-AU$2.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Selling, General & Administrative
-$23.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Selling, General & Administrative
-$2.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-11%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Selling, General & Administrative
-AU$42.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-21%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Selling, General & Administrative
-AU$133.9m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Selling, General & Administrative
-AU$3.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-3%
|
See Also
What is Regeneus Ltd's Selling, General & Administrative?
Selling, General & Administrative
-2.6m
AUD
-2.6m
AUD
Based on the financial report for Dec 31, 2023, Regeneus Ltd's Selling, General & Administrative amounts to -2.6m AUD.
What is Regeneus Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
8%
8%
Over the last year, the Selling, General & Administrative growth was 31%. The average annual Selling, General & Administrative growth rates for Regeneus Ltd have been 12% over the past three years , 7% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
